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Temporal disease trajectories condensed
from population-wide registry data covering
6.2 million patients
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Henriette Schmock5, Peter Bjødstrup Jensen2, Lars Juhl Jensen2 & Søren Brunak1,2
A key prerequisite for precision medicine is the estimation of disease progression from the
current patient state. Disease correlations and temporal disease progression (trajectories)
have mainly been analysed with focus on a small number of diseases or using large-scale
approaches without time consideration, exceeding a few years. So far, no large-scale studies
have focused on deﬁning a comprehensive set of disease trajectories. Here we present a
discovery-driven analysis of temporal disease progression patterns using data from an
electronic health registry covering the whole population of Denmark. We use the entire
spectrum of diseases and convert 14.9 years of registry data on 6.2 million patients into
1,171 signiﬁcant trajectories. We group these into patterns centred on a small number of
key diagnoses such as chronic obstructive pulmonary disease (COPD) and gout, which are
central to disease progression and hence important to diagnose early to mitigate the risk of
adverse outcomes. We suggest such trajectory analyses may be useful for predicting and
preventing future diseases of individual patients.
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P
opulation-wide analyses of disease correlations, co-
morbidities and disease progression have so far mainly
been carried out in a hypothesis-driven manner with focus
on a few diseases1–6 or with focus on co-morbidities to index
diseases7. Although useful in establishing near-term
complications of the disease of interest, these studies are, by
design, constrained to their closely limited and largely, already
established complications. Recently, large-volume health record
analysis was used to uncover associations between patterns of
complex disease and Mendelian loci, demonstrating the validity
of this modelling strategy8. Unfortunately, the nature of the
registry data prevented the investigators from analysing the data
using the key factor of time. This study focuses on frequently
observed temporal patterns over the spectrum of pathologies of
an entire country. Earlier data-driven studies have used a network
approach to analyse data covering 3 years of Medicare claims,
mainly Americans who are 65 years or older, which biased the
analysis to geriatric diagnoses9,10.
The data foundation for the analysis is the Danish National
Patient Registry (NPR), which covers all hospital encounters
(inpatient admissions, outpatient visits and emergency room
visits) of the entire Danish population for a 14.9-year period,
from 1996 to 2010. Mandatory reporting from all Danish
hospitals to the NPR is likely to severely limit the inﬂuence of
population bias. This data set covers 6.2 million patients with a
total of 65 million total clinical encounters, comprising 16 million
hospital inpatient events (24.5% of total), 35 million outpatient
clinic events (53.6% of total) and 14 million emergency
department events (21.9% of total). Together, these encounters
yielded 101 million unique assignments of diagnoses coded in the
International Classiﬁcation of Diseases (ICD-10) terminology.
Here we present the comprehensive set of time dependent,
sequential diagnostic correlations that we have condensed from
the entire population of Denmark. This set of sequential disease
associations, which we deﬁne as disease trajectories, uncovers
time–critical disease associations. They can also form the basis
for understanding mathematical properties of co-morbidity
networks9,10. Both types of studies highlight the potential of
using patient registry data for exploring co-morbidities and the
temporal and non-temporal patterns they display. However, the
data analyses presented here may be more useful, as they exhibit
trajectories that are thus amenable to interruption at various
stages and they point out those stages.
The long time span and the large size of the data set allowed us
to analyse disease progression in the form of diagnosis
trajectories. From the data, we found 1,171 trajectories to have
strong temporal directionality, statistical signiﬁcance and thereby
yield a global picture of the most populated, directional
co-morbidities observed in the clinic. Among these are ﬁve
groups of related trajectories, which allowed us to identify key
diagnoses that can lead to severe outcomes and can thus be used
to deﬁne groups of patients to include in comparative effective-
ness research studies. Our analyses also showed the importance of
stratifying a cohort into inpatient admissions, outpatient visits
and emergency department visits.
Results
Importance of stratiﬁcation for type of hospital encounter.
Disease occurrences correlate strongly with age and gender, and
thus it is an obvious necessity to correct for these underlying
baseline biases. Figure 1 shows distributions of diseases across all
21 ICD-10 chapters in NPR stratiﬁed by age, gender and
encounter type. Gender-speciﬁc differences in trends are clearly
observable. Many diagnoses occur predominantly or exclusively
in the inpatient, outpatient, or emergency department sites. Thus,
a previously unrecognized and fundamentally important stratiﬁ-
cation is also by site of encounter. The fact that the NPR data set
contains signiﬁcantly more outpatient encounters (53.6% of total
encounters) compared with inpatient and emergency department
encounters (24.5 and 21.9% of total encounters, respectively)
further supports the importance of this stratiﬁcation strategy.
Figure 1 summarizes the effect of site of encounter on disease
trajectories. For males, injury codes stand out among young men
(red), but Fig. 1 clearly shows that these diagnoses segregate much
more strongly by encounter type than by gender and age.
This example stands out as one of the strongest correlations
between diagnoses and encounter type, but our analysis demon-
strates that this trend holds true for most ICD-10 chapters. These
data show that it is just as important to stratify diagnoses by the
type of hospital encounter, as by age and gender. An important
consideration in the subsequent analyses was therefore to make
use of this aspect to stratify diagnosis assignments into more
precisely matched groups. In this way, we enable both the
discovery of statistically signiﬁcant correlations that would have
been otherwise masked and the removal of statistically signiﬁcant
correlations that are trivially explained by encounter types.
Temporal co-morbidity analysis as basis for trajectories. To
identify statistically signiﬁcant, temporal correlations among pairs
of diagnoses, we performed a cohort study where exposed
patients who had a speciﬁc pair of diagnoses were matched with
comparison patients with same age, gender and type of hospital
encounter. We performed a pre-ﬁltering step where initial
P-values were estimated initially using a binomial test, and
then conﬁrmed using the full comparison group matching
(see Methods).
From the full data set, we identiﬁed 1,194,343 pairs (D1-D2)
of diagnoses where D2 occurs within a 5-year time frame of D1.
From them, we excluded in total 370,737 codes related to
pregnancy (chapters XV and XVI of ICD-10), general symptoms
and signs not linked to a disease (chapter XVIII), external causes
(chapters XIX and XX) and administration (chapter XXI).
Among the 823,606 tested pairs, we identiﬁed 62,821 that were
observed in at least 10 encounters, had relative risk (RR)41 and
were signiﬁcant in the pre-ﬁltering step with Po1.21 10 9
(binomial tests, Bonferroni corrected for multiple testing). This
number increases byB10,000 if patients are stratiﬁed only by age
and gender, or by type of hospital encounter only, and by an
additionalB8,000 when stratiﬁed by neither (see Table 1). Thus,
stratiﬁcation by type of hospital encounter is complementary to
stratiﬁcation by age and gender, and is equally important.
In addition to identifying pairs with increased risk, we tested
for signiﬁcant directionality: of the pairs D1-D2 with signiﬁcant
RR41, we identiﬁed those where signiﬁcantly higher number of
patients had D1 occurring before D2 compared with the opposite
direction or in the same admission. In all, 4,014 pairs were found
to have a signiﬁcant direction. All pairs were validated using the
sampling model with a Bonferroni-corrected P-value of
o1.21 10 8. Supplementary Data 1 lists all the pairs and their
corresponding RR and P-values. The 4,014 directional pairs were
then combined into longer trajectories consisting of three or more
diagnoses. We identiﬁed a set of 5,784 trajectories with three
diagnoses that cover between 1 and 16,197 patients in the last
step. These were extended to 1,171 trajectories of four diagnoses
covered by at least 20 patients in the last step, 1,077 (92%) of
which have499% bootstrap support. We further validated the
trajectories by comparing them to a set of co-morbid pairs
identiﬁed in a cohort of almost 600,000 individuals from the
greater Stockholm area11. The trajectories capture 48% of
the pairs, which is fourfold more than expected by chance
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(binomial test P¼ 2.2 10 16). The entire set of 1,171 recurrent
trajectories of four diagnoses each is shown in Supplementary
Data 2.
Clustering trajectories reveals disease development patterns.
To produce a more comprehensive overview, we further clustered
the trajectories based on which diagnoses they shared. As a
similarity measure between diagnosis pairs, we used the Jaccard
Index. The clustering identiﬁed 15 clusters; the 5 largest clusters
covered 46, 25, 12, 9 and 8 diagnoses each, respectively. The ﬁve
largest clusters were enriched for diseases of the prostate, chronic
obstructive pulmonary disease (COPD), cerebrovascular disease,
cardiovascular disease and diabetes mellitus, and for space lim-
itations we focus on these below.
The prostate disease cluster is the simplest, progressing from
prostate hypertrophy (ICD-10 code: N40) through prostate
cancer (C61) and obstructive uropathy (N13) to metastatic
cancer (C79) and cancer-associated anaemia (D63) (Fig. 2).
Except for the expected prostate-speciﬁc complications, this
nearly linear trajectory cluster is representative of general cancer
progression to metastasis and anaemia.
The COPD cluster has a characteristic structure, where a
variety of diagnoses, including cardiovascular, skin, endocrine
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Figure 1 | ICD-10 diagnoses from the National Danish Patient Registry covering the entire Danish population in the period 1996–2010. The data panels
show females (left), males (right), inpatients (top), outpatients (middle) and emergency room patients (bottom). The colour-coding corresponds to ICD-10
chapter structure. The chapters are ordered so that the chapters with largest variance in diagnosis count is on top, starting with chapter XV ‘Pregnancy,
childbirth and the puerperium’ and XIX ‘Injury, poisoning and certain other consequences of external causes’, 20 chapters in all.
Table 1 | Number of signiﬁcant pairs (binomial test
Po1.21 109) in the temporal analysis given different
combinations of patient stratiﬁcation.
Age and
gender
Not age
and gender
Type of encounter 62,821 72,832
Not type of encounter 72,937 81,058
Stratifying for either type of hospital encounter or age and gender reduces the total number of
signiﬁcant pairs by 8,121 and 8,226, respectively, compared with no stratiﬁcation, and by 18,237
when stratifying for both. This indicates that stratiﬁcation for type of hospital encounter is as
important as stratiﬁcation by age and gender, and that the two contribute independently.
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and behavioural disorders, converge on COPD (J44) and proceed
to respiratory failure (J96), pneumonia (J15), septicaemia (A41)
and other diagnoses (Fig. 3a). We tested whether COPD was a
central diagnosis in the cluster by calculating the RR of COPD
occurring between all diagnoses preceding and succeeding COPD,
and found that COPD indeed had a large RR of 5.1 (sampling
method Po10 5).
There is wide acceptance that cardiovascular disease-related
morbidities are worsened in patients with COPD2,12–14. This
association, however, generally considers the impact of
cardiovascular events on pre-existing COPD or the co-existence
of the two diagnoses. In contrast, our analysis demonstrates that a
subsequent diagnosis of COPD has a profound impact on a
number of cardiovascular diagnoses, whether angina pectoris
(I20) or atherosclerosis (I70). In fact, all trajectories starting with
atherosclerosis are followed by a subsequent COPD diagnosis,
which supports the temporal pattern of diagnosis as well as
pathophysiologic link. Once the diagnosis of COPD occurs, the
disease trajectories tell a story of rapid progression (typically 1.8–
2.5 years) to a variety of subsequent diagnoses. However, the most
common outcome after COPD is death. Using a Kaplan–Meyer
estimate, we found that 49.7% of patients following a trajectory
containing COPD die within 5 years compared with 21.3% in a
sex-, age- and encounter-matched comparison group. Over the
full data period (14.9 years), 86.9% of these patients die while in
the comparison group 36.2% of patients die. The high-mortality
rate is conﬁrmed in another study15: a 50% mortality at 3.6 years
and 75% at 7.7 years from initial hospitalization.
Similar to the COPD cluster, the cerebrovascular and diabetes
clusters are characterized by convergence on key diagnoses,
namely epilepsy (G40) and retinal disease (H36), respectively
(Figs 3b and 4a). Epilepsy (with an RR of 6.6 for cerebrovascular
disease, sampling method Po10 5) is likely to be a marker of
signiﬁcant cerebrovascular compromise1 reﬂecting the severity of
the underlying disease. Similarly, retinopathy (RR¼ 20.1,
sampling method Po10 5 for diabetes) is a marker of the
degree of system-wide diabetic vasculopathy16; population studies
suggest that diabetic retinopathy is present in more than half of
all diabetics17.
Gout (M10), similar to COPD and retinal disease, is a key
diagnosis within the cardiovascular cluster (RR¼ 6.8, sampling
method Po10 5) and serves as central disease in a diabetes-
independent cardiovascular diseases cluster (Fig. 4b). Associa-
tions between gout and cardiovascular disease have long been
hypothesized18, and allopurinol has recently been suggested for
management of cardiovascular disease19. In contrast, the recent
CHARGE study failed to show a link between serum uric
acid and cardiovascular risk20. Our population-wide trajectory
data support the epidemiologic relationship between gout and
cardiovascular diseases.
Trajectories facilitate comparative effective research. In addi-
tion to providing an important analysis of temporal disease
associations across an entire population, the trajectories and their
associated networks offer a new paradigm to improve trial design
for studies of comparative effectiveness. For example, the four
diagnosis trajectories beginning with angina (I20) as ﬁrst diag-
nosis and ending with cardiac arrest (I46) as fourth diagnosis
include several combinations of diagnoses in the second and third
positions of the trajectories. The subsequent development of
chronic ischaemic heart disease (I25) signiﬁcantly increases the
risk that an angina patient will suffer a cardiac arrest (RR¼ 1.13,
95% conﬁdence interval (95% CI): 1.12–1.42, normal distribution
approximation P¼ 1.38 10 10). Adding the diagnosis of gout
(M10) to the angina and ischaemic heart disease trajectory further
increases the RR of cardiac arrest to 1.99 (95% CI: 1.3–3.05,
normal distribution approximation P¼ 7.66 10 4). In con-
trast, and despite numerous studies that demonstrate the impact
of ischaemic heart disease on increasing the mortality of patients
with renal failure (N18), adding renal failure as a subsequent
diagnosis to angina in the trajectory of angina–ischaemic heart
disease–cardiac arrest does not further increase the risk for car-
diac arrest in the angina patient who develops chronic ischaemic
heart disease. Thus, studies designed to assess the effectiveness of
strategies to prevent cardiac arrest in angina patients could be
tailored to focus on angina patients with both ischaemic heart
disease and gout, as these two diagnoses added subsequently to
the angina diagnosis markedly increase the likelihood of
the outcome of interest (cardiac arrest). See ‘Verifying central
diagnoses’ in Methods for the method description and
Supplementary Table 1 for the statistic summary.
In a similar manner, the trajectory networks presented offer
insights into the complex relationships of end organ pathology of
diabetes (E10) in increasing the likelihood of septicaemia (A41), a
major complication (Supplementary Table 2). The trajectories
demonstrate that the RR of septicaemia is signiﬁcantly increased
by diabetes with subsequent renal failure (N18, RR¼ 3.23,
95% CI: 2.95–3.55, normal distribution approximation P¼ 4.99
 10 139) but not by peripheral vascular diseases or vascular
complications of the eye (disorders of vitreous body, H43,
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Figure 2 | Disease trajectories and trajectory-cluster for prostate cancer.
The ﬁgure illustrates the transition from trajectories to a trajectory cluster.
Each circle represents a diagnosis and is labelled with the corresponding
ICD-10 code. The colours represent different ICD-10 chapters. The
temporal diagnosis progression goes from left to right. (a) All trajectories
that contribute to the prostate-cancer cluster. The number of patients,
who follow the trajectory until a given diagnosis, is given in the edges.
(b) The prostate cancer trajectory cluster that represents all the
trajectories. The width of the edges corresponds to the number of patients
with the directed diagnosis pair from the full population. The cluster
describes a normal progression from having hyperplesia of prostate
diagnosed to having prostate cancer, cancer metastasis and anaemia.
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RR¼ 0.69, normal distribution approximation 95% CI: 0.45–1.04)
and retinopathy. However, the co-occurrence of renal failure and
disorders of vitreous body in any order subsequent to diabetes
results in an RR of septicaemia than renal failure alone of
3.45 (95% CI: 2.08–5.72, normal distribution approximation
P¼ 7.99 10 7), which is greater than renal failure alone.
Discussion
Systematically adding the temporal dimension to population-
wide co-morbidity data using a discovery approach on this scale
has not been attempted previously. We show for the ﬁrst time
that hospitalizations across an entire population of signiﬁcant size
can be used to extract and group trajectories as a novel way of
describing biological disease progression and subsequently
identifying keystone diagnoses.
In this work we deﬁned a diagnosis trajectory as an ordered
series of diagnoses where the diagnoses were observed in the
patients in a speciﬁc order. The order had to be observed strictly
for a patient to be considered following it. Thus, for a trajectory
starting with the diagnoses D1-D2 patients who had the
diagnoses assigned in the order D2-D1-D2 again were not
considered as following the trajectory. In cases where multiple
diagnoses from the trajectory were assigned in the same
discharge, they were considered to be in the correct order.
This strict deﬁnition puts limits on how much variability each
single trajectory is able to cover. It means that bifurcating
diagnoses that later converge on other diagnoses are not included
in a single trajectory. Nonetheless, using our trajectory clustering
approach we were able to cover this type of disease progression as
well. Interestingly, using the clustering approach we were further
able to reduce the patterns of disease progression from 1,171
individual trajectories down to less than ten major clusters
covering most of the populated paths through the disease
terminology space. As the underlying data foundation here is
considerable and unbiased, this condensation is remarkable.
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Figure 4 | Diabetes and cardiovascular disease trajectory clusters. (a) Diabetes cluster showing progression from non-insulin-dependent to
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However, it does also obviously reﬂect the numerical constraints
set of the requirement for directionality in terms of RR.
In terms of trajectory interpretation, it is essential eventually to
establish to what extent the directionality reﬂect underlying
causal patterns or not. For example, it is interesting to speculate
whether the disease state associated with the COPD diagnosis is
the cause, or whether COPD is an ICD-10 surrogate for a variety
of factors associated with increased morbidity, such as smoking,
adverse effects of medications, or poor general health.
The expected high degree of association between COPD and
atherosclerosis supports the obvious smoking linkage. Hospita-
lization for pneumonia in the setting of underlying chronic
disease is common, with odds ratios reported at 4.4 for COPD
and 3.2 for heart failure in one large study21. Our model suggests
an even more profound effect of these chronic conditions on
pneumonia within a relatively short time span. COPD as a
subsequent diagnosis of many trajectories may also demonstrate a
medical systems issue, namely that of undiagnosed and therefore
untreated or undertreated COPD, which becomes manifest only
after another serious diagnosis is made. It is likely to be that
COPD is coexistent with the initial diagnosis of most trajectories,
yet it occurs as a second data point in multiple trajectories.
The ability to make data-supported inferences of disease
severity and of medical systems issues demonstrates the power
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Figure 5 | Illustration of the random sampling procedure with N samplings for the co-morbidity of diagnosis A followed by diagnosis B within 1 year.
(a) All discharges with diagnosis A assigned are identiﬁed for all patients to make the exposed discharges group. Each exposed discharge is matched with a
set of N randomly chosen comparison patients with the same gender and age group as the exposed patient and a discharge of the same type in the same
week. Each line in a shows a single exposed patient discharge and its matched comparison patient discharge. (b) The diagnosis history of the exposed
and comparison cases and controls is examined to see whether diagnosis B occurred within 1 year of the matched week in which the case had diagnosis
A (a blue box indicates that diagnosis B occurs within the time frame). X, Y and Z represents arbitrary other diagnoses. (c) The number of these
occurrences is counted for each cohort giving a number of overlaps. The count for the cases is the observed overlap, while the control cohorts are used
to estimate the P-values.
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of the trajectory analysis. A recent study of 5,812 Danish
COPD patients, using extensive questionnaire data, physical
examination, lung function and medication data has now
provided epidemiologic corroboration, demonstrated a strong,
consistent pattern of undertreatment and suggested
underdiagnosis of Danes with COPD22. The disease trajectories
and networks presented here provide the opportunity to conduct
a systemic analysis to identify such gaps in disease recognition,
diagnosis and treatment.
Our ﬁndings demonstrate that the population-wide disease
trajectory approach uncovers diagnosis linkages that have had
unclear or conﬂicting relationships through epidemiologic or
smaller sample cohort approaches. We further demonstrate the
importance of patient stratiﬁcation and that stratiﬁcation by type
of hospital encounter is as important as stratiﬁcation by age and
gender.
The trajectories have also a predictive potential where
preceding steps can be used as a basis for predicting the most
probable next step in disease progression. A major additional
perspective in using the catalogue of disease trajectories
established here is obviously to use them in the context of
stratiﬁcation for precision medicine and combine them with
detailed molecular level characterization of each patient,
for example, whole-exome or genome sequencing, for better
disease management of individual patients along the course each
patient will take.
Methods
Study design. The objective of this retrospective cohort study was to identify and
characterize disease trajectories using population-wide disease registry data
using a data-driven approach. The trajectories were derived using pairs of
signiﬁcant time-dependent diagnosis correlations.
The data used in the analysis is from the Danish NPR, which contains
administrative information and primary and secondary diagnoses coded in the
ICD-10, covering every hospital contact in Denmark. It includes public and private
hospital visits and covers all types of encounters: inpatient (admitted to the hospital
with overnight stay), outpatient (visit without overnight stay) and emergency
department contacts.
The data set covers the period January 1996 to November 2010, and includes
68 million records for 6.2 million individuals. For inpatients, the records cover the
time between admission to a ward until discharge to either another ward or out
of the hospital. Records covering two or more discharges between wards were
combined into one covering the entire admission. In cases of re-admissions the
same or the following day after a discharge, the records were also combined.
Doing this, 1.5 million inpatient records were combined with other records giving
66.5 million encounters in total. As private hospitals have only reported contacts
from 2002, all of these, in total 1 million, were removed to maintain an unbiased
data set. Private hospitals in Denmark approximately handle o1.6% of all
admissions (routine treatment) and add o1% unique patient diagnosis
associations as 38.4% of the patient diagnosis associations from private hospital
are already covered by the public hospitals.
The ICD-10 system has a hierarchical structure, where codes can be rounded
to a less speciﬁc parent diagnosis code, block or chapter. We used this structure
to round all codes to level 3 codes.
Diagnosis correlation measure. We used RR to measure the strength of the
correlation between a pair of diagnoses (D1-D2) within 5 years. RR estimates and
associated P-values were calculated using a sampling approach, where a number of
comparison groups were matched to the exposed patients. For this, the exposed
group was formed by identifying all discharges with D1 assigned. Comparison
groups were formed by matching each of these discharges with a random discharge
from the full population. To account for confounding factors, comparison patients
were matched to come from the same age and gender group as the exposed patients
(as shown in Supplementary Fig. 1). The type of encounter was matched for the D1
discharge. The season of the year and possible changes in diagnostic methods and
focus over years were controlled for by sampling the comparison discharge from
the same week as the case D1 discharge.
We sampled a number (N) of comparison groups. Subsequently, D1 discharges
that have one or more subsequent D2 discharges within a 5-year time frame were
counted for all groups (Fig. 5). We denote the number for the exposed group as
Cexposed and as Ci, where i¼ 1. N is for the comparison groups. RR is given by,
RR ¼ Cexp osed1
N
P
i
Ci
ð1Þ
The P-value was calculated as the percentage of the comparison groups with a
total co-occurrence counts that is larger than the observed co-occurrence count,
P ¼ 1
N
i Ci  Cexp osed
  ð2Þ
RR was estimated using 10,000 sampled comparison groups for each pair of
diagnoses. Owing to correction for multiple testing for 823,606 pairs, we needed
more than 82 million samples for each pair to obtain a signiﬁcant P-value.
A binomial model was used as a pre-ﬁltering step to avoid a total running time
of several thousands of computing years if performing the full procedure. Pairs
included in the trajectories were validated using the full sampling procedure.
In the binomial test modelling the sampling procedure, we considered each
sampling of a single comparison discharge as a Bernoulli trial. Given the matching
criteria, there is a set of nmatch discharges to select the random comparison group
discharge from. A number, c, of these discharges will have D2 discharge within
the time frame. This number can be pre-calculated without any sampling.
The probability of sampling a comparison group discharge with a D2 discharge
within the time frame is,
Pr D2ð Þ ¼ c
nmatch
ð3Þ
The probability distribution for the total number of sampled D2 discharges
is the sum of all single Bernoulli trials. We approximated the distribution with a
single binomial test that uses the average of the probabilities for all D1 discharges
as probability parameter,
PrðD2Þtest ¼
1
ndischarges
Xndischarges
i¼1
ci
nmatch;i
ð4Þ
where ndischarges is the number of discharges with D1.
To make sure the binomial model is a valid substitution for the sampling giving
P-values that are at least as conservative as the sampling procedure, we ran full
sampling for 1,500 pairs and compared with the simpliﬁcation. We expect the
simpliﬁcation to perform worst where the variance of the probabilities contributing
to the average probability is high. Therefore, we tested the 1,000 pairs with the
largest variance, while 500 others were chosen at random. Figure 6 shows the
true P-values plotted against estimated P-values. The binomial model was found to
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Figure 6 | Validation of P-values estimated with binomial testing. Each
point represents the sampled P-value and the difference between estimated
and sampled for a pair of diagnoses for some time limit. The estimated
P-values are from the model with one population average and positive
difference implies that the estimated model is more conservative. The fact
that the estimated model is more conservative for small P-values reduced
the likelihood that using the estimate will cause a false positive. As an extra
precaution against false positives, we used a P-value cut-off of 0.001
(before correction) when using the binomial estimated P-values.
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be more conservative than the sampled P-values for small P-value. Thus, the
simpliﬁcation is a valid substitute for the sampling procedure. To further guard
against false positives due to the binomial model, the signiﬁcance cutoff level was
set to 0.001.
Testing for directionality. The diagnosis pairs (D1, D2) that had RR41 and a
signiﬁcant P-value for one or both directions (D1-D2 and/or D2-D1) were
tested for directionality. Binomial tests were used to identify pairs where sig-
niﬁcantly more patient had D1 assigned before D2 or the other way around. For
this, the ﬁrst D1 and D2 discharges for patients with both diagnoses were identiﬁed
and the order for each patient established. The number of patients with each order
of the diagnoses was counted: ND1 with D1 assigned ﬁrst, ND2 with D2 assigned
ﬁrst and Nsame with D1 and D2 in the same discharge. Using two binomial tests, we
tested whether ND1 or ND2 were signiﬁcantly larger compared with a binomial
distribution (ND1þNsameþND2 samples with probability 50%). The P-values were
Bonferroni corrected. If one of the tests showed a P-value o0.05, the pair was
considered having a signiﬁcant direction (only one of the tests can have signiﬁcant
P-value).
Diagnosis trajectories. We counted the patients as following a disease trajectory
only if the patient had the diagnoses assigned strictly in the order speciﬁed by
the trajectory. Each step of the trajectory corresponded to a single diagnosis.
We used the pairs of diagnoses from the temporal correlation analysis with
signiﬁcant direction to identify the trajectories to count. Trajectories with three
diagnoses were obtained by combining pairs with overlapping diagnoses (D1-D2
and D2-D3 combined to D1-D2-D3). They were subsequently extended with
more overlapping pairs to obtain even longer trajectories. A greedy approach was
used to ﬁnd the three long trajectories covering the most patients. The pairs were
sorted in descending order according to their discharge count. Pairs with an
overlapping diagnosis were found starting from the top of the list and the number
of patients following the full trajectory was counted. We stopped when the three
long trajectories had no patients following them. All four and ﬁve long trajectories
were then counted. Using this approach, all the trajectories covering the largest
number of patients can be identiﬁed without counting every possible trajectory.
To establish the robustness of the trajectories, we calculated a bootstrap value
for each trajectory by resampling the population. As the cutoff for a trajectory to be
in the ﬁnal set was a minimum of 20 patients, the bootstrap value is the proportion
of the trajectories that have 20 or more patients in the resampled populations. In
our case, this bootstrap approach is equivalent to a series of Bernoulli trials where a
patient is drawn from the population and success is deﬁned as drawing a patient
who follows the trajectory. Given a trajectory with N patients in the last step and a
population of Npop¼ 6.2 million, the randomly sampled trajectory count (C)
follows a binomial distribution with CBB(ntrials¼Npop, P¼N/Npop). The
bootstrap support will thus converge to the probability P(CZ20) as the number
of bootstrapped samples approach inﬁnity. Consequently, the support can be
calculated through a binomial test and will be identical for all trajectories that are
followed by the same number of patients.
Comparison with co-morbidities from Stockholm, Sweden. To validate that the
diagnosis pairs within the trajectories are not unique to the Danish population, we
compared them against a study of co-morbidities in a cohort of almost 600,000
individuals from the greater Stockholm area11. We used the top 1000 co-
morbidities, which are made available through Comorbidity-View (http://
www2.dsv.su.se/comorbidityview-demo/, accessed: 25 February 2014). Our
trajectories consist of 140 unique diagnoses, which can be combined into 9,730
unique undirected pairs. The trajectories contain 1,155 unique pairs, if for a
trajectory D1-y-D4 we include all six possible combinations of pairs
([D1,D2], [D1,D3], [D1,D4], [D2,D3], [D2,D4], [D3,D4]). Of the top 1,000 pairs
in the Swedish study, 221 pairs consist of 2 diagnoses that can be found in our
trajectories, 106 of which (48%) fall within the set of 1,155 trajectory pairs.
We compared this with random expectation using a binomial test B(ntrials¼ 206,
P¼ 9,730/1,115).
Diagnosis trajectory clustering. In the 1,171 four long diagnosis trajectories we
identiﬁed groups of trajectories having large diagnosis overlap and representing
variants of general patterns of disease progression. To identify these patterns
systematically, we used the Markov Cluster Algorithm23 that assigned each of the
140 codes that make up the 1,171 trajectories to a cluster. The Jaccard index was
used as similarity measure (counting how many trajectories both diagnoses are part
of and normalizing by the total number of trajectories either is part of). Trajectories
with all diagnoses within the same cluster were combined into directed trajectory
clusters in which the patterns could be examined (Figs 2–4).
As the clustering was based on diagnoses, some trajectories had diagnoses from
multiple clusters. Of the original 1,171 trajectories, there were 378 that had all
diagnoses within the same cluster. We increased this number to 608 by merging
one smaller cluster into the largest and by including particular diagnoses to clusters
if they contributed to complete trajectories with three diagnoses already within the
cluster. In this way, some diagnoses appear in multiple clusters. Of the 608
trajectories, 466 were within the largest cluster, 129 within the second largest
cluster, 6 within the third largest, 5 within the fourth largest and 2 in each their
cluster. The second largest through the fourth largest cluster each revealed a
distinct pattern of disease progression (the COPD, cerebrovascular and prostate
cancer patterns), whereas the largest cluster had two major patterns in it:
one focusing on diabetes mellitus and another focusing on cardiovascular
diagnoses.
To divide the largest cluster into the two patterns, the diagnoses within it
were once again clustered using MCL. We used the same similarity measure as
before, but using larger inﬂation factor. This resulted in four new sub-clusters,
where the largest subcluster covered diabetes mellitus diagnoses. We merged
the second and third largest subclusters, which together covered cardiovascular
diagnoses.
Finally, the ﬁve clusters were visualized by representing diagnoses as nodes
and making directed edges between consecutive diagnoses for all the trajectories
within the same cluster.
Verifying central diagnoses. In most of the trajectory clusters, we identiﬁed a key
diagnosis. To verify that they are central to the disease progression in the clusters,
we, for each key diagnosis, counted how often it occurred between diagnoses
preceding it and diagnoses succeeding it in the full population. We identiﬁed
two sets of diagnoses: all diagnoses that could lead to the key diagnoses (the
preceding set) and all diagnoses that could be reached from the key diagnoses (the
succeeding set). Next, we identiﬁed all exposed patients who had one diagnosis
from the preceding set followed by one from the succeeding set. Similar to when
counting the trajectories, we discarded patients who have a diagnosis from the
succeeding set before the ﬁrst from the preceding set, and the diagnoses were
allowed to occur in the same admission. We then counted the patients having their
ﬁrst occurrences of the key diagnosis in the time from the ﬁrst occurrence of a
preceding diagnosis to the ﬁrst occurrence of a succeeding diagnosis.
To evaluate the count of the key diagnosis, we calculated RR and assigned
P-values by matching comparison groups using the same criteria as for the
temporal correlation analysis. For each exposed patient, we identiﬁed the number
of days between the occurrences of the preceding diagnosis to the occurrence of the
succeeding diagnosis. We counted the number of occurrences of the key diagnosis
in the same period among the matched comparison patients. The ﬁndings are
summarized in Supplementary Table 3.
In addition, we investigated which combination of key diagnoses could lead to
severe outcome in the cardiovascular and diabetes trajectory groups. Severe
outcome was deﬁned as cardiac arrest in the cardiovascular network and as
septicaemia in the diabetes trajectory group. Patients following a trajectory starting
with angina pectoris (cardiovascular trajectory group) or insulin-dependent
diabetes mellitus were stratiﬁed on the presence of all possible combinations of
key diagnoses within trajectories leading to this outcome. For each combination
of diagnoses, we counted the number of patients with and without the severe
outcome, and RR was calculated. P-values were approximated with a normal
distribution. Supplementary Tables 1 and 2 shows the statistics for the
cardiovascular trajectory group and the diabetes trajectory group, respectively.
Data and materials approval. The NPR registry data is protected by the Danish
Act on Processing of Personal Data and can only be accessed following application.
This study has been approved by Danish Data Registration Agency,
Copenhagen (ref: 2010–54–1059) and the National Board of Health, Copenhagen
(ref: 7–505–29–1624/1).
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